Your browser doesn't support javascript.
loading
Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies.
Ryan, Maureen C; Palanca-Wessels, Maria Corinna; Schimpf, Brian; Gordon, Kristine A; Kostner, Heather; Meyer, Brad; Yu, Changpu; Van Epps, Heather A; Benjamin, Dennis.
Afiliação
  • Ryan MC; Department of Translational Research and.
  • Palanca-Wessels MC; Department of Clinical Development, Seattle Genetics, Inc., Bothell, WA.
  • Schimpf B; Department of Translational Research and.
  • Gordon KA; Department of Translational Research and.
  • Kostner H; Department of Translational Research and.
  • Meyer B; Department of Translational Research and.
  • Yu C; Department of Translational Research and.
  • Van Epps HA; Department of Translational Research and.
  • Benjamin D; Department of Translational Research and.
Blood ; 130(18): 2018-2026, 2017 11 02.
Article em En | MEDLINE | ID: mdl-28903943

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirróis / Benzodiazepinas / Linfoma de Células B / Antígenos CD19 / Anticorpos Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirróis / Benzodiazepinas / Linfoma de Células B / Antígenos CD19 / Anticorpos Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article